AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1540108 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild aversive stimulus (bitter substance painted on nails)
Number of subjects: 21
Study 1540108 — intervention group
Group type: EXPERIMENTAL
Intervention: Competing response therapy (performing a competing response when the urge to bite occurs)
Number of subjects: 21
Study 1540108 — intervention group
Group type: COMPARATOR
Intervention: Self-monitoring alone
Number of subjects: 21
Study 2870990 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine combined with propranolol (80 mg twice daily)
Number of subjects: 6
Study 2870990 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine combined with betaxolol (20 mg once daily)
Number of subjects: 6
Study 2870990 — intervention group
Group type: COMPARATOR
Intervention: Propranolol alone (80 mg twice daily)
Number of subjects: 6
Study 2870990 — intervention group
Group type: COMPARATOR
Intervention: Betaxolol alone (20 mg once daily)
Number of subjects: 6
Study 31755587 — intervention group
Group type: EXPERIMENTAL
Intervention: S‐ibuprofen
Number of subjects: 22
Study 31755587 — intervention group
Group type: COMPARATOR
Intervention: R‐ibuprofen
Number of subjects: 22
Study 31755587 — intervention group
Group type: COMPARATOR
Intervention: Achiral method
Number of subjects: 22
Study 27872384 — intervention group
Group type: EXPERIMENTAL
Intervention: Happy Being Me ‐ Appearance Comparison
Number of subjects: 260
Study 27872384 — intervention group
Group type: EXPERIMENTAL
Intervention: Happy Being Me ‐ Media Literacy
Number of subjects: 260
Study 27872384 — intervention group
Group type: COMPARATOR
Intervention: Happy Being Me ‐ Healthy Eating Behaviour
Number of subjects: 260
Study 28050987 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthesia with adrenaline
Number of subjects: 100
Study 28050987 — intervention group
Group type: COMPARATOR
Intervention: Local anesthesia without adrenaline
Number of subjects: 100
Study 27031099 — intervention group
Group type: EXPERIMENTAL
Intervention: Biweekly acupuncture treatments for 6 months (group 1)
Number of subjects: 104
Study 27031099 — intervention group
Group type: COMPARATOR
Intervention: Weekly acupuncture treatments after 2 months of waitlist (group 2)
Number of subjects: 104
Study 25457926 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional Treatment Foster Care (MTFC)
Number of subjects: 100
Study 25457926 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 100
Study 23058022 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline (2.7% sodium chloride solution), administered twice-daily using a disposable 20 ml syringe for 4 weeks
Number of subjects: 220
Study 23058022 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal saline, administered twice-daily using a disposable 20 ml syringe for 4 weeks
Number of subjects: 220
Study 23058022 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 220
Study 19534034 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared Decision Making (SDM)
Number of subjects: 86
Study 19534034 — intervention group
Group type: COMPARATOR
Intervention: Control (Education Program)
Number of subjects: 86
Study 17300595 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg q.d.
Number of subjects: 1172
Study 17300595 — intervention group
Group type: COMPARATOR
Intervention: Glipizide 5 mg/day (uptitrated to a maximum of 20 mg/day)
Number of subjects: 1172
Study 15286110 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth Morphology (computer-assisted learning program)
Number of subjects: 45
Study 15286110 — intervention group
Group type: COMPARATOR
Intervention: Lecture (traditional lecture)
Number of subjects: 45
Study 11142674 — intervention group
Group type: EXPERIMENTAL
Intervention: PerioChip (chlorhexidine gluconate 2.5 mg)
Number of subjects: 26
Study 11189161 — intervention group
Group type: EXPERIMENTAL
Intervention: Predforte (10% prednisolone acetate) administered transnasally to the operative cavity
Number of subjects: 75
Study 7706104 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextrose-saline solution containing 1 IU per ml of heparin
Number of subjects: 80
Study 7706104 — intervention group
Group type: COMPARATOR
Intervention: Control solutions (without heparin)
Number of subjects: 80
Study 2618526 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocolloid dressing (Comfeel Ulcus) in Group 1
Number of subjects: 58
Study 2618526 — intervention group
Group type: COMPARATOR
Intervention: Compression stockings in Group 2
Number of subjects: 58
Study 2618526 — intervention group
Group type: COMPARATOR
Intervention: Group 2 (serum levels of iron, zinc, copper, selenium measured)
Number of subjects: 58
Study 2618526 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (3 mm punch biopsy for histopathological examination)
Number of subjects: 58
Study 2618526 — intervention group
Group type: COMPARATOR
Intervention: Group 2 (temperature difference measurement)
Number of subjects: 58
Study 2618526 — intervention group
Group type: COMPARATOR
Intervention: Group 2 (ulcer pH measurement)
Number of subjects: 58
Study 2618526 — intervention group
Group type: COMPARATOR
Intervention: Group 2 (serum levels comparison)
Number of subjects: 58
Study 908352 — intervention group
Group type: EXPERIMENTAL
Intervention: Frank lead vectorcardiogram (VCG), orthogonal electrocardiogram (ECG), and standard scalar ECG measurements in 78 patients
Number of subjects: 112
Study 908352 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation of the regression equation in 34 patients
Number of subjects: 112
Study 30746976 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation (PMR) with morphine 0.15 mg/kg daily in divided doses
Number of subjects: 70
Study 30746976 — intervention group
Group type: COMPARATOR
Intervention: Control group with morphine 0.15 mg/kg daily in divided doses
Number of subjects: 70
Study 28806791 — intervention group
Group type: EXPERIMENTAL
Intervention: Open book (UpToDate) with typical time
Number of subjects: 825
Study 28806791 — intervention group
Group type: EXPERIMENTAL
Intervention: Open book (UpToDate) with additional time
Number of subjects: 825
Study 28806791 — intervention group
Group type: COMPARATOR
Intervention: Closed book with typical time
Number of subjects: 825
Study 28806791 — intervention group
Group type: COMPARATOR
Intervention: Closed book with additional time
Number of subjects: 825
Study 28806791 — intervention group
Group type: COMPARATOR
Intervention: Closed book conditions
Number of subjects: 825
Study 28806791 — intervention group
Group type: EXPERIMENTAL
Intervention: Open book conditions
Number of subjects: 825
Study 25253432 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS (1 mA, 15 min)
Number of subjects: 26
Study 25253432 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS (1 mA, 15 min)
Number of subjects: 26
Study 25253432 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 26
Study 25253432 — intervention group
Group type: EXPERIMENTAL
Intervention: Paired F-VEPs
Number of subjects: 26
Study 23905554 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-operative iv administration of fluid boluses based on stroke volume measured by oesophageal Doppler (probe arm)
Number of subjects: 74
Study 23905554 — intervention group
Group type: COMPARATOR
Intervention: iv fluid based on clinical indicators (no-probe arm)
Number of subjects: 74
Study 21919372 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ketamine (0.125 mg/kg) plus clonidine (0.5 microg/kg)
Number of subjects: 68
Study 21919372 — intervention group
Group type: COMPARATOR
Intervention: Intravenous placebo (sodium chloride 0.9%)
Number of subjects: 68
Study 19826560 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (50 mg) as add-on to standard treatment for alcohol dependence
Number of subjects: 108
Study 19826560 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment for alcohol dependence without sildenafil
Number of subjects: 108
Study 16419069 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (AC)
Number of subjects: 350
Study 15280526 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin infusion (20 mU/min)
Number of subjects: 20
Study 15280526 — intervention group
Group type: COMPARATOR
Intervention: dDAVP (2 micro g subcutaneously)
Number of subjects: 20
Study 15280526 — intervention group
Group type: COMPARATOR
Intervention: Control (no oxytocin or dDAVP)
Number of subjects: 20
Study 11343530 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive-expressive group therapy for 1 year
Number of subjects: 125
Study 11343530 — intervention group
Group type: COMPARATOR
Intervention: Educational materials only (Control)
Number of subjects: 125
Study 9217118 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon dioxide laser
Number of subjects: 98
Study 9217118 — intervention group
Group type: COMPARATOR
Intervention: Electrocautery
Number of subjects: 98
Study 8488748 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 59
Study 8488748 — intervention group
Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 59
Study 6601445 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexabrix
Number of subjects: 51
Study 6601445 — intervention group
Group type: COMPARATOR
Intervention: Renografin 60
Number of subjects: 51
Study 31537527 — intervention group
Group type: EXPERIMENTAL
Intervention: Plerixafor (400 μg/kg/day) infused intravenously for 4 consecutive weeks starting at day 35 of concurrent chemoradiation.
Number of subjects: 29
Study 31537527 — intervention group
Group type: EXPERIMENTAL
Intervention: Plerixafor (400 μg/kg/day)
Number of subjects: 29
Study 31537527 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI and histopathology analysis
Number of subjects: 29
Study 29748109 — intervention group
Group type: EXPERIMENTAL
Intervention: rasagiline 1 mg/day
Number of subjects: 404
Study 29748109 — intervention group
Group type: EXPERIMENTAL
Intervention: rasagiline 0.5 mg/day
Number of subjects: 404
Study 29748109 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 404
Study 27358154 — intervention group
Group type: EXPERIMENTAL
Intervention: lipid-lowering nutraceutical
Number of subjects: 80
Study 25150911 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-meal video game playing (VGP) for 30 minutes
Number of subjects: 19
Study 25150911 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose preload (50g in 250mL of water)
Number of subjects: 19
Study 25150911 — intervention group
Group type: COMPARATOR
Intervention: No pre-meal video game playing (no-VGP)
Number of subjects: 19
Study 25150911 — intervention group
Group type: COMPARATOR
Intervention: Non-caloric sucralose control
Number of subjects: 19
Study 25150911 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective appetite measured at 0, 15, 30, and 60 minutes
Number of subjects: 19
Study 25150911 — intervention group
Group type: EXPERIMENTAL
Intervention: Frustration and aggression scores after VGP
Number of subjects: 19
Study 25150911 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline and pre-meal happiness and excitement scores
Number of subjects: 19
Study 21971943 — intervention group
Group type: EXPERIMENTAL
Intervention: GB-0998 (high-dose intravenous immunoglobulin therapy)
Number of subjects: 26
Study 21971943 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 19204077 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise on prescription intervention
Number of subjects: 1089
Study 19204077 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1089
Study 17949325 — intervention group
Group type: EXPERIMENTAL
Intervention: Extraperitoneal approach
Number of subjects: 62
Study 17949325 — intervention group
Group type: COMPARATOR
Intervention: Transperitoneal approach
Number of subjects: 62
Study 16786813 — intervention group
Group type: EXPERIMENTAL
Intervention: Facial electromyography (EMG) method
Number of subjects: 32
Study 16786813 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects (control)
Number of subjects: 32
Study 15300236 — intervention group
Group type: EXPERIMENTAL
Intervention: CSP and MMF
Number of subjects: 40
Study 15300236 — intervention group
Group type: COMPARATOR
Intervention: CSP and MTX
Number of subjects: 40
Study 10812286 — intervention group
Group type: EXPERIMENTAL
Intervention: Marijuana (3.55% Delta(9)-THC)
Number of subjects: 5
Study 10812286 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0% THC)
Number of subjects: 5
Study 10812286 — intervention group
Group type: COMPARATOR
Intervention: Naltrexone (0, 50, or 200 mg)
Number of subjects: 5
Study 8966499 — intervention group
Group type: EXPERIMENTAL
Intervention: SYSTEN 50
Number of subjects: 30
Study 8966499 — intervention group
Group type: EXPERIMENTAL
Intervention: MENOREST 50
Number of subjects: 30
Study 1854464 — intervention group
Group type: COMPARATOR
Intervention: DuP 753 (2.5, 5, 10, 20, and 40 mg single dose)
Number of subjects: 0
Study 1854464 — intervention group
Group type: COMPARATOR
Intervention: DuP 753 (5, 10, 20, or 40 mg multiple dose, once daily for eight days)
Number of subjects: 0
Study 1854464 — intervention group
Group type: COMPARATOR
Intervention: Placebo (single and multiple doses)
Number of subjects: 0
Study 6396118 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifonazole 1% cream
Number of subjects: 29
Study 6396118 — intervention group
Group type: COMPARATOR
Intervention: Bifonazole cream vehicle
Number of subjects: 29
Study 31162858 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted mild hypothermia in organ donors after neurologic determination of death
Number of subjects: 0
Study 31162858 — intervention group
Group type: COMPARATOR
Intervention: Standard donor management practice using static cold storage
Number of subjects: 0
Study 31162858 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted mild hypothermia
Number of subjects: 0
Study 28877011 — intervention group
Group type: EXPERIMENTAL
Intervention: Tezepelumab 70 mg every 4 weeks
Number of subjects: 584
Study 28877011 — intervention group
Group type: EXPERIMENTAL
Intervention: Tezepelumab 210 mg every 4 weeks
Number of subjects: 584
Study 28877011 — intervention group
Group type: EXPERIMENTAL
Intervention: Tezepelumab 280 mg every 2 weeks
Number of subjects: 584
Study 28877011 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 584
Study 25741666 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine (n = 296)
Number of subjects: 567
Study 25741666 — intervention group
Group type: COMPARATOR
Intervention: Traditional surveillance (n = 271)
Number of subjects: 567
Study 25741666 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine (n = 409 participants total after offering to both groups)
Number of subjects: 567
Study 25741666 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine (n = 271 to 208 participants)
Number of subjects: 567
Study 22989326 — intervention group
Group type: EXPERIMENTAL
Intervention: Accumulated brisk walking programme (15 min in the morning and afternoon, at least three times a week for 15 weeks)
Number of subjects: 152
Study 22989326 — intervention group
Group type: COMPARATOR
Intervention: Usual school day activities (Control)
Number of subjects: 152
Study 21298236 — intervention group
Group type: EXPERIMENTAL
Intervention: Periarticular infiltration with triamcinolone acetonide, bupivacaine and epinephrine
Number of subjects: 100
Study 21298236 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine and epinephrine (Control)
Number of subjects: 100
Study 19339704 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil and isoflavone placebo (FO)
Number of subjects: 10
Study 19339704 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil placebo and isoflavones (ISO)
Number of subjects: 10
Study 19339704 — intervention group
Group type: COMPARATOR
Intervention: Fish oil placebo and isoflavone placebo (placebo)
Number of subjects: 10
Study 19339704 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil and isoflavones (FO + ISO)
Number of subjects: 10
Study 16737850 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 325mg
Number of subjects: 197
Study 16737850 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 197
Study 16737850 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study 15201716 — intervention group
Group type: EXPERIMENTAL
Intervention: PMMA lens
Number of subjects: 10
Study 15201716 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenestrated lens
Number of subjects: 10
Study 11153782 — intervention group
Group type: EXPERIMENTAL
Intervention: Group learning program based on personal construct theory (12 meetings, 4 hours every 2 weeks from February 1997 to October 1997)
Number of subjects: 116
Study 11153782 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 116
Study 9432316 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole plus amoxicillin treatment regimen
Number of subjects: 384
Study 9432316 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori eradication assessment at 1 month posttreatment
Number of subjects: 384
Study 9432316 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall efficiency of H. pylori tests
Number of subjects: 384
Study 8384171 — intervention group
Group type: EXPERIMENTAL
Intervention: Group counselling (GC group)
Number of subjects: 60
Study 8384171 — intervention group
Group type: COMPARATOR
Intervention: Individual counselling (IC group)
Number of subjects: 60
Study 3811804 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 0.002 mg/kg
Number of subjects: 60
Study 3811804 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 0.004 mg/kg
Number of subjects: 60
Study 3811804 — intervention group
Group type: COMPARATOR
Intervention: Control group (no fentanyl)
Number of subjects: 60
Study 30075898 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion (0.5 µg/kg/h) during cardiopulmonary bypass
Number of subjects: 70
Study 30075898 — intervention group
Group type: COMPARATOR
Intervention: Propofol continuous intravenous infusion (50 to 70 µg/kg/min)
Number of subjects: 70
Study 30259127 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation (Lactobacillus casei, Bifidobacterium lactis, Lactobacillus rhamnosus, Lactobacillus plantarum, fructooligosaccharide, galactooligosaccharide, and biotin) for 8 weeks
Number of subjects: 320
Study 30259127 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation
Number of subjects: 320
Study 26913388 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab combined with fludarabine and cyclophosphamide
Number of subjects: 40
Study 26913388 — intervention group
Group type: COMPARATOR
Intervention: CHOP chemotherapy
Number of subjects: 40
Study 25411294 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-enteric-coated (non-EC) granules (500 mg)
Number of subjects: 49
Study 25411294 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-enteric-coated (non-EC) granules (1000 mg)
Number of subjects: 49
Study 25411294 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-enteric-coated (non-EC) granules (1500 mg)
Number of subjects: 49
Study 25411294 — intervention group
Group type: COMPARATOR
Intervention: Enteric-coated (EC) granules (500 mg)
Number of subjects: 49
Study 25411294 — intervention group
Group type: COMPARATOR
Intervention: Enteric-coated (EC) granules (1000 mg)
Number of subjects: 49
Study 25411294 — intervention group
Group type: COMPARATOR
Intervention: Enteric-coated (EC) granules (1500 mg)
Number of subjects: 49
Study 25411294 — intervention group
Group type: COMPARATOR
Intervention: Cumulative 48-h FCA of EC calcium
Number of subjects: 49
Study 25411294 — intervention group
Group type: EXPERIMENTAL
Intervention: FCA for 1000 mg dose compared to 500 mg
Number of subjects: 49
Study 25411294 — intervention group
Group type: EXPERIMENTAL
Intervention: FCA for 1500 mg dose compared to 500 mg
Number of subjects: 49
Study 22420492 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEAS 50 mg daily
Number of subjects: 14
Study 22420492 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 20978193 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum 25-hydroxyvitamin D (25(OH)D) levels <25 nmol/L
Number of subjects: 250
Study 20978193 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum 25-hydroxyvitamin D (25(OH)D) levels 25 to <37.5 nmol/L
Number of subjects: 250
Study 20978193 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum 25-hydroxyvitamin D (25(OH)D) levels 37.5 to <50 nmol/L
Number of subjects: 250
Study 20978193 — intervention group
Group type: EXPERIMENTAL
Intervention: Season-specific quartiles Q1 versus Q4
Number of subjects: 250
Study 18603279 — intervention group
Group type: EXPERIMENTAL
Intervention: Coextensive gratings with higher contrast
Number of subjects: 0
Study 18603279 — intervention group
Group type: EXPERIMENTAL
Intervention: Coextensive gratings with lower contrast
Number of subjects: 0
Study 18603279 — intervention group
Group type: EXPERIMENTAL
Intervention: Gratings moving in opposite directions with a vertical gap of 1 degree or more
Number of subjects: 0
Study 18603279 — intervention group
Group type: EXPERIMENTAL
Intervention: Gratings moving in the same direction with a vertical gap of 8 degrees
Number of subjects: 0
Study 16037731 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 800 mg (in two equally divided doses)
Number of subjects: 60
Study 16037731 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 12577433 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative traditional Chinese and western medicine (TCM‐WM)
Number of subjects: 120
Study 12577433 — intervention group
Group type: COMPARATOR
Intervention: Chinese herbal medicine alone (TCM)
Number of subjects: 120
Study 12577433 — intervention group
Group type: COMPARATOR
Intervention: Western medicine alone (WM)
Number of subjects: 120
Study 9701192 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal graded exercise test
Number of subjects: 14
Study 9701192 — intervention group
Group type: COMPARATOR
Intervention: 30‐min rest period
Number of subjects: 14
Study 8024076 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronized halofantrine (8 mg/kg every 6 hr in three doses)
Number of subjects: 102
Study 8024076 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine (25 mg/kg for a 48-hr period) plus clindamycin (5 mg/kg every 12 hr in six doses)
Number of subjects: 102
Study 8024076 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine (25 mg/kg for a 48-hr period) plus doxycycline (2 mg/kg every 12 hr in six doses)
Number of subjects: 102
Study 2557685 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium phosphate remineralizing slurry (CPRS) for 10 minutes
Number of subjects: 3